Abstract

Immunochemical techniques are the workhorse for sample enrichment and detection of a large variety of analytes. In contrast to classical microtiter plate-based assays, microparticles are a next generation solid support, as they promote automation of immunoassays using flow-based techniques. Antibody immobilization is a crucial step, as these reagents are expensive, and inefficient coupling can result in low sensitivities. This paper proposes a general procedure for efficient immobilization of antibodies onto TentaGel particles, via N-hydroxysuccinimide chemistry. The goal was the preparation of solid supports with optimum immunorecognition, while increasing the sustainability of the process. The influence of buffer composition, activation and coupling time, as well as the amount of antibody on the immobilization efficiency was investigated, resorting to fluorophore-labeled proteins and fluorescence imaging. Buffer pH and activation time are the most important parameters for efficient coupling. It is demonstrated, that the hydrolysis of N-hydroxysuccinimide esters occurs at similar rates as in solution, limiting the utilizable time for coupling. Finally, applicability of the generated material for automated affinity extraction is demonstrated on the mesofluidic platform lab-on-valve.

Highlights

  • NHS ester-mediated immobilization of proteins in aqueous phases is usually carried out using N-(3-dimethylaminopropyl)-N0-ethyl carbodiimide (EDC) as water-soluble carbodiimide compound in a one-pot synthesis [11, 27, 28]

  • The here applied reaction scheme is depicted in S1 Fig. To circumvent this kinetically limiting factor, commercially available carboxyl-modified TentaGel beads offer the possibility of NHS activation in organic media (e.g. DMF), preventing hydrolysis before the actual coupling of the protein takes place in aqueous phase

  • Fluorescence intensity showed statistically significant differences (p < 0.05) between the positive and the negative batches

Read more

Summary

Introduction

Antibody conjugation to carboxyl-modified microspheres europa.eu/regional_policy/en/funding/erdf/) and National Funds (FCT/MEC - Ministerio da Educacão e Ciência) under the Partnership Agreements PT2020 UID/QUI/50006/2013 to MAS and UID/ MULTI/04378/2013. Daad.de) and Conselho de Reitores das Universidades Portuguesas (www.crup.pt) under the protocol CRUP-DAAD (Acões Integradas Luso-Alemãs noE-20/16) to PC and RJS is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.